glucose, (beta-d)-isomer has been researched along with vildagliptin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Abiru, N; Ando, T; Horie, I; Kawakami, A; Shigeno, R | 1 |
| Mudher Mikhael, E | 1 |
| Hua, WC; Li, CM; Liu, Q; Wang, H; Wang, LG | 1 |
| Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Kerdphoo, S; Pratchayasakul, W; Sa-Nguanmoo, P; Tanajak, P | 1 |
| Chattipakorn, N; Chattipakorn, SC; Sa-Nguanmoo, P; Siri-Angkul, N; Sivasinprasasn, S; Tanajak, P; Thummasorn, S | 1 |
| Chattipakorn, N; Chattipakorn, S; Gunaparn, S; Jaiwongkam, T; Kumfu, S; Phrommintikul, A; Wongcharoen, W | 1 |
| Htun, KT; Intachai, N; Jaikumkao, K; Kothan, S; Lungkaphin, A; Promsan, S; Swe, MT; Tapanya, M; Thongnak, L | 1 |
| Al-Dhubiab, BE; Attimarad, M; Elgorashe, REE; Shafi, S; Venugopala, KN | 1 |
| Fan, X; Guo, F; Huang, F; Liu, Y; Qin, G; Song, Y; Zhao, L | 1 |
| Barkatestrong/Strong, H; Khaladkar, K; Mohan, B; Suryawanshi, S | 1 |
| Abidi, H; Ahmed, M; Khan, A; Khan, IA | 1 |
2 review(s) available for glucose, (beta-d)-isomer and vildagliptin
| Article | Year |
|---|---|
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients.
Topics: Adamantane; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Fasting; Glucagon-Like Peptide-1 Receptor; Glucosides; Holidays; Humans; Hypoglycemia; Hypoglycemic Agents; Islam; Liraglutide; Nitriles; Peptides; Pyrrolidines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Venoms; Vildagliptin | 2016 |
A network meta-analysis for efficacy and safety of seven regimens in the treatment of type II diabetes.
Topics: Adamantane; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucosides; Humans; Hypoglycemic Agents; Metformin; Network Meta-Analysis; Nitriles; Pyrrolidines; Randomized Controlled Trials as Topic; Treatment Outcome; Vildagliptin | 2017 |
3 trial(s) available for glucose, (beta-d)-isomer and vildagliptin
| Article | Year |
|---|---|
Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study.
Topics: Aged; Benzhydryl Compounds; Biomarkers; Blood Glucose; Blood Pressure; China; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Inflammation Mediators; Lipids; Male; Middle Aged; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome; Troponin T; Vildagliptin | 2019 |
Efficacy and Safety of a Fixed Dose Combination of Remogliflozin Etabonate and Vildagliptin in Patients with Type-2 Diabetes Mellitus: A Randomized, Active-Controlled, Double-Blind, Phase III Study.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Linagliptin; Metformin; Prospective Studies; Pyrazoles; Treatment Outcome; Vildagliptin | 2022 |
Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population.
Topics: Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pakistan; Vildagliptin | 2022 |
6 other study(ies) available for glucose, (beta-d)-isomer and vildagliptin
| Article | Year |
|---|---|
Low-carbohydrate diet combined with SGLT2 inhibitor for refractory hyperglycemia caused by insulin antibodies.
Topics: Adamantane; Aged; Benzhydryl Compounds; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Drug Therapy, Combination; Glucosides; Humans; Hypoglycemic Agents; Insulin; Insulin Antibodies; Insulin Resistance; Male; Metformin; Nitriles; Pyrrolidines; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin | 2016 |
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Apoptosis; Benzhydryl Compounds; Brain; Cognition Disorders; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Insulin; Insulin Resistance; Long-Term Potentiation; Male; Malondialdehyde; Maze Learning; Membrane Potential, Mitochondrial; Memory; Mitochondria; Neuroprotective Agents; Nitriles; Obesity; Oxidative Stress; Pyrrolidines; Rats, Wistar; Reactive Oxygen Species; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin | 2017 |
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Cytoprotection; Diet, High-Fat; Glucosides; Heart; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Function, Left; Vildagliptin | 2018 |
Dapagliflozin ameliorates pancreatic injury and activates kidney autophagy by modulating the AMPK/mTOR signaling pathway in obese rats.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autophagy; Benzhydryl Compounds; Diet, High-Fat; Endoplasmic Reticulum Stress; Gene Expression Regulation; Glucose Tolerance Test; Glucosides; Inflammation; Kidney; Magnetic Resonance Imaging; Male; Malondialdehyde; Obesity; Oxidative Stress; Pancreas; Rats, Wistar; Signal Transduction; TOR Serine-Threonine Kinases; Vildagliptin | 2021 |
Development of Ecofriendly Derivative Spectrophotometric Methods for the Simultaneous Quantitative Analysis of Remogliflozin and Vildagliptin from Formulation.
Topics: Glucosides; Pyrazoles; Solvents; Spectrophotometry; Spectrophotometry, Ultraviolet; Vildagliptin | 2021 |
Identification of circular RNAs and functional competing endogenous RNA networks in human proximal tubular epithelial cells treated with sodium-glucose cotransporter 2 inhibitor dapagliflozin in diabetic kidney disease.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetic Nephropathies; Epithelial Cells; Glucose; Glucosides; Humans; Hypoglycemic Agents; In Situ Hybridization, Fluorescence; Metformin; MicroRNAs; RNA, Circular; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Vildagliptin | 2022 |